Literature DB >> 25773483

Kidney Failure and ESRD in the Atherosclerosis Risk in Communities (ARIC) Study: Comparing Ascertainment of Treated and Untreated Kidney Failure in a Cohort Study.

Casey M Rebholz1, Josef Coresh2, Shoshana H Ballew2, Blaithin McMahon2, Seamus P Whelton2, Elizabeth Selvin2, Morgan E Grams2.   

Abstract

BACKGROUND: Linkage to the US Renal Data System (USRDS) registry commonly is used to identify end-stage renal disease (ESRD) cases, or kidney failure treated with dialysis or transplantation, but it underestimates the total burden of kidney failure. This study validates a kidney failure definition that includes both kidney failure treated and not treated by dialysis or transplantation. It compares kidney failure risk factors and outcomes using this broader definition with USRDS-identified ESRD risk factors and outcomes. STUDY
DESIGN: Diagnostic test study with stratified random sampling of hospitalizations for chart review. SETTING &amp; PARTICIPANTS: Atherosclerosis Risk in Communities Study (n=11,530; chart review, n=546). INDEX TEST: USRDS-identified ESRD; treated or untreated kidney failure defined by USRDS-identified ESRD or International Classification of Diseases, Ninth or Tenth Revision, Clinical Modification (ICD-9-CM/ICD-10-CM) code for hospitalization or death. REFERENCE TEST: For ESRD, determination of permanent dialysis therapy or transplantation; for kidney failure, determination of permanent dialysis therapy, transplantation, or estimated glomerular filtration rate < 15 mL/min/1.73 m(2).
RESULTS: During 13 years' median follow-up, 508 kidney failure cases were identified, including 173 (34.1%) from the USRDS registry. ESRD and kidney failure incidence were 1.23 and 3.66 cases per 1,000 person-years in the overall population and 1.35 and 6.59 cases per 1,000 person-years among participants older than 70 years, respectively. Other risk-factor associations were similar between ESRD and kidney failure, except diabetes and albuminuria, which were stronger for ESRD. Survivals at 1 and 5 years were 74.0% and 24.0% for ESRD and 59.8% and 31.6% for kidney failure, respectively. Sensitivity and specificity were 88.0% and 97.3% comparing the kidney failure ICD-9-CM/ICD-10-CM code algorithm to chart review; for USRDS-identified ESRD, sensitivity and specificity were 94.9% and 100.0%. LIMITATIONS: Some medical charts were incomplete.
CONCLUSIONS: A kidney failure definition including treated and untreated disease identifies more cases than linkage to the USRDS registry alone, particularly among older adults. Future studies might consider reporting both USRDS-identified ESRD and a more inclusive kidney failure definition.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis Risk in Communities (ARIC) Study; End-stage renal disease (ESRD); US Renal Data System (USRDS); chronic kidney disease (CKD); chronic kidney failure; hospitalization; renal replacement therapy (RRT); sensitivity and specificity; untreated renal failure; validation studies

Mesh:

Substances:

Year:  2015        PMID: 25773483      PMCID: PMC4516566          DOI: 10.1053/j.ajkd.2015.01.016

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  23 in total

Review 1.  Early start of dialysis: a critical review.

Authors:  Steven Rosansky; Richard J Glassock; William F Clark
Journal:  Clin J Am Soc Nephrol       Date:  2011-05       Impact factor: 8.237

2.  A predictive model for progression of chronic kidney disease to kidney failure.

Authors:  Navdeep Tangri; Lesley A Stevens; John Griffith; Hocine Tighiouart; Ognjenka Djurdjev; David Naimark; Adeera Levin; Andrew S Levey
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

3.  Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial.

Authors:  F L Brancati; P K Whelton; B L Randall; J D Neaton; J Stamler; M J Klag
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

4.  Withholding and withdrawing dialysis: the role of physician specialty and education and patient functional status.

Authors:  M A Sekkarie; A H Moss
Journal:  Am J Kidney Dis       Date:  1998-03       Impact factor: 8.860

5.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

6.  Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Lori D Bash; Brad C Astor; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2009-11-22       Impact factor: 8.860

7.  The contribution of increased diabetes prevalence and improved myocardial infarction and stroke survival to the increase in treated end-stage renal disease.

Authors:  Paul Muntner; Josef Coresh; Neil R Powe; Michael J Klag
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

8.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

9.  Receipt of renal replacement therapy in the United States: a population-based study of sociodemographic disparities from the Second National Health and Nutrition Examination Survey (NHANES II).

Authors:  Neil R Powe; Michelle E Tarver-Carr; Mark S Eberhardt; Frederick L Brancati
Journal:  Am J Kidney Dis       Date:  2003-08       Impact factor: 8.860

10.  Chronic kidney disease and the risk of end-stage renal disease versus death.

Authors:  Lorien S Dalrymple; Ronit Katz; Bryan Kestenbaum; Michael G Shlipak; Mark J Sarnak; Catherine Stehman-Breen; Stephen Seliger; David Siscovick; Anne B Newman; Linda Fried
Journal:  J Gen Intern Med       Date:  2010-09-19       Impact factor: 5.128

View more
  29 in total

1.  Prevalence and recognition of chronic kidney disease in Stockholm healthcare.

Authors:  Alessandro Gasparini; Marie Evans; Josef Coresh; Morgan E Grams; Olof Norin; Abdul R Qureshi; Björn Runesson; Peter Barany; Johan Ärnlöv; Tomas Jernberg; Björn Wettermark; Carl G Elinder; Juan-Jesüs Carrero
Journal:  Nephrol Dial Transplant       Date:  2016-10-13       Impact factor: 5.992

2.  Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.

Authors:  Benjamin Lazarus; Yuan Chen; Francis P Wilson; Yingying Sang; Alex R Chang; Josef Coresh; Morgan E Grams
Journal:  JAMA Intern Med       Date:  2016-02       Impact factor: 21.873

3.  Biomarkers of Vitamin D Status and Risk of ESRD.

Authors:  Casey M Rebholz; Morgan E Grams; Pamela L Lutsey; Andrew N Hoofnagle; Jeffrey R Misialek; Lesley A Inker; Andrew S Levey; Elizabeth Selvin; Chi-Yuan Hsu; Paul L Kimmel; Ramachandran S Vasan; John H Eckfeldt; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2015-10-23       Impact factor: 8.860

4.  Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.

Authors:  Yan Chen; Alex R Chang; Mara A McAdams DeMarco; Lesley A Inker; Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Morgan E Grams
Journal:  Mayo Clin Proc       Date:  2016-08-04       Impact factor: 7.616

5.  Race, APOL1 Risk, and eGFR Decline in the General Population.

Authors:  Morgan E Grams; Casey M Rebholz; Yuan Chen; Andreea M Rawlings; Michelle M Estrella; Elizabeth Selvin; Lawrence J Appel; Adrienne Tin; Josef Coresh
Journal:  J Am Soc Nephrol       Date:  2016-03-10       Impact factor: 10.121

6.  Particulate Matter and Albuminuria, Glomerular Filtration Rate, and Incident CKD.

Authors:  Matthew F Blum; Aditya Surapaneni; James D Stewart; Duanping Liao; Jeff D Yanosky; Eric A Whitsel; Melinda C Power; Morgan E Grams
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-27       Impact factor: 8.237

7.  Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Emily A Hu; Elizabeth Selvin; Morgan E Grams; Lyn M Steffen; Josef Coresh; Casey M Rebholz
Journal:  Am J Kidney Dis       Date:  2018-03-20       Impact factor: 8.860

8.  Diet Soda Consumption and Risk of Incident End Stage Renal Disease.

Authors:  Casey M Rebholz; Morgan E Grams; Lyn M Steffen; Deidra C Crews; Cheryl A M Anderson; Lydia A Bazzano; Josef Coresh; Lawrence J Appel
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-26       Impact factor: 8.237

9.  The Loss of GSTM1 Associates with Kidney Failure and Heart Failure.

Authors:  Adrienne Tin; Robert Scharpf; Michelle M Estrella; Bing Yu; Megan L Grove; Patricia P Chang; Kunihiro Matsushita; Anna Köttgen; Dan E Arking; Eric Boerwinkle; Thu H Le; Josef Coresh; Morgan E Grams
Journal:  J Am Soc Nephrol       Date:  2017-07-18       Impact factor: 10.121

10.  Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.

Authors:  Casey M Rebholz; Elizabeth Selvin; Menglu Liang; Christie M Ballantyne; Ron C Hoogeveen; David Aguilar; John W McEvoy; Morgan E Grams; Josef Coresh
Journal:  Kidney Int       Date:  2017-08-31       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.